These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34245387)

  • 1. Expression of an immunocomplex consisting of Fc fragment fused with a consensus dengue envelope domain III in Saccharomyces cerevisiae.
    So KK; Chun J; Luong NN; Seo HW; Kim DH
    Biotechnol Lett; 2021 Sep; 43(9):1895-1904. PubMed ID: 34245387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and purification of an immunogenic dengue virus epitope using a synthetic consensus sequence of envelope domain III and Saccharomyces cerevisiae.
    Nguyen NL; Kim JM; Park JA; Park SM; Jang YS; Yang MS; Kim DH
    Protein Expr Purif; 2013 Apr; 88(2):235-42. PubMed ID: 23376461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of cell-surface displayed synthetic consensus dengue EDIII cells as a potent oral vaccine candidate.
    Bal J; Jung HY; Nguyen LN; Park J; Jang YS; Kim DH
    Microb Cell Fact; 2018 Sep; 17(1):146. PubMed ID: 30217208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative immunogenicity of preparations of yeast-derived dengue oral vaccine candidate.
    Bal J; Luong NN; Park J; Song KD; Jang YS; Kim DH
    Microb Cell Fact; 2018 Feb; 17(1):24. PubMed ID: 29452594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and characterization of an M cell-specific ligand-fused dengue virus tetravalent epitope using Saccharomyces cerevisiae.
    Nguyen NL; So KK; Kim JM; Kim SH; Jang YS; Yang MS; Kim DH
    J Biosci Bioeng; 2015 Jan; 119(1):19-27. PubMed ID: 25027708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. M cell-targeting ligand and consensus dengue virus envelope protein domain III fusion protein production in transgenic rice calli.
    Kim TG; Kim MY; Huy NX; Kim SH; Yang MS
    Mol Biotechnol; 2013 Jul; 54(3):880-7. PubMed ID: 23250723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elaboration of tetravalent antibody responses against dengue viruses using a subunit vaccine comprised of a single consensus dengue envelope sequence.
    Sun J; Li M; Wang Y; Hao P; Jin X
    Vaccine; 2017 Nov; 35(46):6308-6320. PubMed ID: 28987441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and assembly of cholera toxin B subunit and domain III of dengue virus 2 envelope fusion protein in transgenic potatoes.
    Kim MY; Li JY; Tien NQ; Yang MS
    Protein Expr Purif; 2017 Nov; 139():57-62. PubMed ID: 27335159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ removal of consensus dengue virus envelope protein domain III fused to hydrophobin in Pichia pastoris cultures.
    Cerezo J; Smith ME; Rodríguez Talou J
    Protein Expr Purif; 2019 Jan; 153():131-137. PubMed ID: 30240632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice.
    Arora U; Tyagi P; Swaminathan S; Khanna N
    Vaccine; 2013 Jan; 31(6):873-8. PubMed ID: 23261049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple production of hydrophobin-fused domain III of dengue envelope protein and induction of neutralizing antibodies against the homotypic serotype of dengue virus.
    Cerezo J; Targovnik AM; Smith ME; González Maglio D; Luppo VC; Morales MA; Miranda MV; Rodríguez Talou J
    Biotechnol Lett; 2020 Mar; 42(3):419-428. PubMed ID: 31828570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dengue-4 envelope domain III fused twice within the meningococcal P64k protein carrier induces partial protection in mice.
    Lazo L; Zulueta A; Hermida L; Blanco A; Sánchez J; Valdés I; Gil L; López C; Romero Y; Guzmán MG; Guillén G
    Biotechnol Appl Biochem; 2009 Apr; 52(Pt 4):265-71. PubMed ID: 18636968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of chimeric DNA vaccines consisting of premembrane and envelope genes of Japanese encephalitis and dengue viruses as a strategy for reducing induction of dengue virus infection-enhancing antibody response.
    Sjatha F; Kuwahara M; Sudiro TM; Kameoka M; Konishi E
    Microbiol Immunol; 2014 Feb; 58(2):126-34. PubMed ID: 24372832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2.
    Arora U; Tyagi P; Swaminathan S; Khanna N
    J Nanobiotechnology; 2012 Jul; 10():30. PubMed ID: 22794664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of binding of dengue virus envelope protein to target cells.
    Chen Y; Maguire T; Marks RM
    J Virol; 1996 Dec; 70(12):8765-72. PubMed ID: 8971005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plant-expressed Fc-fusion protein tetravalent dengue vaccine with inherent adjuvant properties.
    Kim MY; Copland A; Nayak K; Chandele A; Ahmed MS; Zhang Q; Diogo GR; Paul MJ; Hofmann S; Yang MS; Jang YS; Ma JK; Reljic R
    Plant Biotechnol J; 2018 Jul; 16(7):1283-1294. PubMed ID: 29223138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DENV-2 subunit proteins fused to CR2 receptor-binding domain (P28)-induces specific and neutralizing antibodies to the Dengue virus in mice.
    García-Machorro J; López-González M; Barrios-Rojas O; Fernández-Pomares C; Sandoval-Montes C; Santos-Argumedo L; Villegas-Sepúlveda N; Gutiérrez-Castañeda B; Cedillo-Barrón L
    Hum Vaccin Immunother; 2013 Nov; 9(11):2326-35. PubMed ID: 23880886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineered Dengue Virus Domain III Proteins Elicit Cross-Neutralizing Antibody Responses in Mice.
    Frei JC; Wirchnianski AS; Govero J; Vergnolle O; Dowd KA; Pierson TC; Kielian M; Girvin ME; Diamond MS; Lai JR
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and protective efficacy of a recombinant fusion protein containing the domain III of the dengue 1 envelope protein in non-human primates.
    Bernardo L; Izquierdo A; Alvarez M; Rosario D; Prado I; López C; Martínez R; Castro J; Santana E; Hermida L; Guillen G; Guzmán MG
    Antiviral Res; 2008 Nov; 80(2):194-9. PubMed ID: 18602424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dimerization of Dengue Virus E Subunits Impacts Antibody Function and Domain Focus.
    Thomas A; Thiono DJ; Kudlacek ST; Forsberg J; Premkumar L; Tian S; Kuhlman B; de Silva AM; Metz SW
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32611757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.